Dr. Lundberg defended her thesis in 1996 at Lund University on the topic of ex vivo gene therapy to the brain. She was a Wenner-Gren Fellow at Harvard Medical School in Professor Richard C. Mulligan’s lab during the years 1996 through 1998. She started her own research group at the Wallenberg Neuroscience Center in 2002 and received full professorship in 2011.
Lundberg’s research interests have always circled around development of novel therapies to treat neurodegenerative diseases with a particular emphasis on Parkinson’s disease. She has developed cell specific vectors for use in the CNS as well as ways to regulate transgene expression.
Cell-specific Lentiviral Vectors to Target and Normalize GAD 67 Expression in enkephalinergic striatal out-put neurons in experimental Parkinson's Disease